Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides
Clinical trial NCT04201808 · UNKNOWN
Trial details
- NCT number
- NCT04201808
- Sponsor
- New Discovery LLC
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2023-09-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.